Lorus Therapeutics Inc. (T.LOR) hit a new 52-week high of 12.5 cents; Lorus Therapeutics Inc., a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, today announced a publication demonstrating the antitumor activity of a novel cytokine interleukin 17E (IL-17E).
The article entitled "IL-17E, a pro-inflammatory cytokine, has antitumor efficacy against several tumor types in vivo" was published in the peer-reviewed journal, Cancer Immunology Immunotherapy, and is currently available online on the Journal's website.
Intact Financial Corp. (T.IFC) hit a new 52-week high of $41.83; no news announcements today
Chariot Resources Ltd. (T.CHD) hit a new 52-week high of 63 cents; no news announcements today
Open Text Corp (T.OTC) hit a new 52-week high of $50.76; no news announcements today
Brookfield Properties Corp. (T.BPO) hit a new 52-week high of $14.15; no news announcements today
Morguard Corp. (T.MRC) hit a new 52-week high of $36.67; no news announcements today
Emerge Oil And Gas Inc (T.EME) hit a new 52-week high of $4.39; no news announcements today
Related Stories
